Venture Insights

What investors actually underwrite

Founders pitch the upside. Investors underwrite the risk. Most fundraising difficulty lives in the gap between those two activities.

A founder builds a deck to answer "how big can this get?" It's the natural question — it's why they started the company. Every slide builds toward the size of the prize.

An investor, reading the same deck, is running a different process entirely. They are asking: what has to be true for this to work, which of those things is already true, and which am I being asked to take on faith? Then they're pricing that gap.

Once you see the conversation this way, a lot of confusing feedback resolves. "Too early for us" often means "too many unretired risks at once." "We love the team but..." usually means the team risk is retired and something else isn't.

The four risks

Nearly every early-stage investment decision decomposes into four questions.

Market risk. Do enough people have this problem, badly enough, and can you reach them affordably? Not TAM — TAM slides are treated as noise by anyone experienced. The real question is whether the specific customers you can actually reach have this problem urgently.

Product risk. Can this be built, and does it solve the problem well enough that people change behavior? Behavior change is the hard part and where most consumer and workflow products die.

Go-to-market risk. Can you acquire customers repeatably at a cost that works? A company with ten customers, all sourced from the founder's network, has not retired this. That's fine at pre-seed; it's a serious problem at Series A.

Team risk. Is this the group that can execute through the version of this problem that exists in three years, not the one that exists today?

Your valuation is essentially a function of how many of these four you have retired, and how convincingly.

Structure the narrative around what's retired

The most effective fundraising narratives I've seen are explicit about this. They say, in effect: here are the four things that had to be true. Here are the two we've proven, with evidence. Here is the one we're raising this round to prove. Here is the one we're honestly still taking on faith, and here's why we think that's the right risk to hold.

This feels dangerous to founders. Naming your weakest area seems like handing the investor a reason to decline.

In practice it does the opposite, for two reasons. It demonstrates that you understand your own business at the level a good investor does, which is itself a strong signal about the team. And it prevents the far worse dynamic where the investor discovers the unretired risk themselves in diligence, and now doubts everything else you claimed.

Evidence, in order of weight

Not all proof is equal. Roughly, from strongest to weakest:

  1. Revenue from customers with no relationship to you, renewing.
  2. Revenue from strangers, too early to renew.
  3. Usage data showing genuine behavior change — retention curves that flatten.
  4. Signed pilots or LOIs with real money attached.
  5. Customer interviews where they describe the problem in their own words, unprompted.
  6. Your conviction, and the logic behind it.

Founders frequently lead with six and hold four in an appendix. Invert it. A single flattened retention curve moves an investor more than ten slides of reasoning.

The round is a story about the next round

Something founders underweight: an investor at seed is not primarily asking "will this be a big company?" They're asking "will this be able to raise a strong Series A?"

That reframing is practically useful. It means your raise should be sized and planned around retiring the specific risks that the next investor will care about. A raise that funds eighteen months of building without retiring a named risk is a raise that ends in a difficult conversation.

State this explicitly: "This round takes us to [specific milestone], which retires [specific risk], which is what a Series A investor in this category underwrites." You have just done part of their job for them.

What doesn't move the needle

In rough order of overuse: TAM calculated top-down from an industry report. Competitor grids where you win every row. Hockey-stick projections with no stated assumptions. "We have no competitors." Advisor logos from people who took one call. Vanity metrics without denominators.

None of these are fatal. They're just noise, and noise costs you the scarce minutes when the investor is actually paying attention.

The thing that matters most

After all the frameworks: the strongest signal is a founder who has clearly thought harder about their own business than the investor across the table.

You can't fake it and you can't deck your way around it. It shows up in the quality of the questions you ask back, in how precisely you describe what you don't yet know, and in whether your answer to an objection is defensive or genuinely curious.


I look at these from both sides — helping founders build the narrative, and evaluating them as an investor. The gap between the two views is usually where the work is.

← All insights Work with me →

Facing this in your own company?

Essays are the general case. Your situation is the specific one — that's the conversation worth having.